Navigation Links
Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
Date:3/28/2011

BASKING RIDGE, N.J., March 28, 2011 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.

The presentation, "A Randomized, Partially-Blinded, Multi-Center, Active-Controlled, Dose-ranging Study Assessing the Safety, Efficacy and Pharmacodynamics of the REG1 Anticoagulation System Compared to Unfractionated Heparin or Low Molecular Weight Heparin in Subjects with Acute Coronary Syndromes: Primary Results of the RADAR Randomized Clinical Trial," will be given during an i2 Special Session entitled: "Interventional Featured Clinical Studies I" on Sunday, April 3, 2011 at 1:15 p.m. CDT at the Ernest N. Morial Convention Center in New Orleans, LA.

REG1 comprises a two-component system; a highly selective Factor IXa inhibiting aptamer, pegnivacogin, and its complementary specific active control agent, anivamersen.  Anivamersen can be used to selectively reverse (completely or partially) the anticoagulant effect of pegnivacogin in real time.

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent.  This technology is being applied to injectable antithrombotics (including antico
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
2. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
3. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
4. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
5. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
6. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
7. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
8. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
9. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
10. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
11. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, ... in translational preclinical research, today unveiled their new logo ... the transformation of Surpass, corporate culture to one where ... customers. This press release comes on the heels of ... added to the Silicon Valley Team:  David Craig, a ...
(Date:7/23/2014)... Ill. , July 23, 2014 ... IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY ... THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ... 2014 financial results on Friday, July 25, 2014, before the ... of the earnings conference call at 8 a.m. Central time ...
(Date:7/23/2014)... 2014  RT Oncology Services Corporation today announced that ... board of directors. Mr. Mundie is currently senior advisor ... on strategic projects within the company and on technology ... and strategy officer. Mike Martin ... "Craig is a visionary technology executive. His appointment is ...
Breaking Medicine Technology:SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... In Children,s DNA, a Hint of a Mutation,s Ancestral ... researchers,seeking to replicate another group,s discovery of an important ... a particular,variant in DNA that may be more helpful ... populations worldwide. The finding suggests that,the gene variant, identified ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announced ... clinical study of ANX-510, CoFactor(R), for the treatment ... at the 2008,American Society of Clinical Oncology (ASCO) ... 3, 2008 in Chicago, IL., The poster ...
Cached Medicine Technology:Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 2ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 3
(Date:7/23/2014)... Global Cardio Care, Inc., a management company ... is celebrating the 100th birthday of Albert Weber, ... center. , Weber has been plagued with angina ... therapy since 1999, he no longer suffers from either ... Cardio Care, introduced the Sara Soulati Health For ...
(Date:7/23/2014)... Calif. Fragile X syndrome ( FXS ) is ... and other behaviors on the autistic spectrum, as well ... cause of mental impairment and the most common cause ... of California, Riverside have published a study ... in FXS. Appearing online today (July 23) in the ...
(Date:7/23/2014)... Four hospitals affiliated with the Allegheny Health ... of the country’s best hospitals by U.S. News ... slated for publication in August, the U.S. News 2014-2015 ... Hospital, Saint Vincent Hospital and West Penn Hospital as ... , “There is no higher priority at Allegheny ...
(Date:7/23/2014)... 2014 (HealthDay News) --,Jealousy may not be the sole ... get downright possessive when it comes to the love ... toward what was actually a stuffed dog, the real ... the stuffed dog aside, report researchers from the University ... only surfaced when owners were attending to the stuffed ...
(Date:7/23/2014)... to catalog the molecular causes of stomach cancer, ... identified four subtypes of tumors based on shared ... new classification promises to advance clinical research to ... worldwide. , In a report in Nature ... Network said they analyzed 295 samples of gastric ...
Breaking Medicine News(10 mins):Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Dogs Can Get Jealous, Too 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... filtering, which experts prefer , , THURSDAY, May 21 (HealthDay ... not only frees up time during their days but ... new study suggests. , Although lifesaving, dialysis is time-consuming ... dialysis, a newer option, actually takes longer but is ...
... MDTH ), a healthcare provider focused on high acuity healthcare ... its operating results for its second quarter of fiscal 2009, which ... , Net revenue up 3.0% ... revenue up 4.0% , Adjusted ...
... MA May, 21, 2009 Agios Pharmaceuticals, the ... cancer metabolism drugs, announced that the leading scientific journal ... the Warburg Effect: The Metabolic Requirements of Cell ... Cantley, Ph.D., Director of the Cancer Center at Beth ...
... May 21 The following is ... for Tobacco-Free Kids:(Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... U.S. Senator Patty Murray (D-WA) for voting to ... Drug Administration (FDA) regulatory authority over tobacco products, ...
... Support Recently Launched Military ProgramSHORT HILLS, N.J., May ... the national, non-profit organization dedicated to finding cures ... the lives of people living with paralysis, announced ... from TD Bank,s charitable giving arm, the TD ...
... The following is a statement from Matthew ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) The Campaign ... (D-MD) for voting Wednesday to approve legislation that ... regulatory authority over tobacco products, including the authority ...
Cached Medicine News:Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 2Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 3Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 4Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 5Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 6Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 7Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 8Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 9Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 10Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 11Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 12Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 13Health News:MedCath Corporation Reports Second Quarter Earnings and Provides Update to Internal Assessment 14Health News:Agios Pharmaceuticals' founders author Science review on cancer metabolism 2Health News:Sen. Patty Murray Votes to Protect America's Kids from Tobacco 2Health News:Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank 2Health News:Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank 3Health News:Sen. Barbara Mikulski Votes to Protect America's Kids from Tobacco 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: